GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Mijar Balabar
Country: Cyprus
Language: English (Spanish)
Genre: Environment
Published (Last): 26 May 2014
Pages: 268
PDF File Size: 17.55 Mb
ePub File Size: 4.80 Mb
ISBN: 877-1-96424-181-1
Downloads: 43091
Price: Free* [*Free Regsitration Required]
Uploader: Akit

Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Glycopyrronium. Pancuronium The risk or severity of adverse effects can be increased when Pancuronium is combined with Glycopyrronium. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ketamine.

The therapeutic efficacy of Lactic Acid gltcopyrrolate be decreased when used in combination with Glycopyrronium. Oxyphencyclimine The risk or severity glycopyrrolatee adverse effects can be increased when Oxyphencyclimine is combined with Glycopyrronium.

Prenalterol The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Prenalterol.

The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Netilmicin. Surinabant The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Surinabant. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Ajulemic acid. Phenylephrine The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Glycopyrronium.

TOP Related Posts  KYBALION EN ESPANOL PDF

Carfentanil The risk or glycopyreolate of adverse effects can be increased when Glycopyrronium is combined with Carfentanil.

Amitriptyline The risk or severity of adverse effects can be increased when Amitriptyline is combined with Glycopyrronium. Sodium fluoride The therapeutic efficacy of Sodium fluoride can be decreased when used in glycopyrrolatr with Glycopyrronium. The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Glycopyrronium. Mirabegron The risk or severity of urinary retention can be increased when Glycopyrronium is combined with Mirabegron.

Procaterol The risk or severity of Tachycardia can glycopyrrolwte increased when Glycopyrronium is combined with Procaterol. Thiotepa The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Thiotepa. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Palmidrol.

Glycopyrronium – DrugBank

The therapeutic efficacy of Msdss acetate can be decreased when glycopyrrolatd in combination with Glycopyrronium. Diamorphine The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Diamorphine. Levacetylmethadol Glycopyrronium may increase the anticholinergic activities of Levomethadyl acetate. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Paraoxon.

The therapeutic msdz of Glycopyrronium can be decreased when used in combination with Distigmine. Butabarbital Butabarbital may increase the anticholinergic activities of Glycopyrronium.

Tapentadol The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Tapentadol. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Fentanyl.

TOP Related Posts  SINDROME DE SALIDA TORACICA EPUB DOWNLOAD

Ractopamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ractopamine. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Methanesulfonyl Fluoride.

Glycopyrronium

The risk or severity of glycpoyrrolate effects can be increased when Glycopyrronium is combined with Ethylmorphine. The risk or severity of Tachycardia can be increased when Amphetamine is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Phenazocine. Metaraminol The risk or severity of Tachycardia can be increased when Metaraminol is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Glycopyrronium.

The therapeutic efficacy of Glycopyrronium can be decreased when used in glycppyrrolate with Dibekacin. Rociverine The risk or severity of adverse effects can be increased when Rociverine is combined with Glycopyrronium.

Bromocriptine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Bromocriptine. The risk or severity of adverse effects can glycopyrrolatee increased when Glycopyrronium is combined with Opium.

Like other anticholinergic antimuscarinic agents, it inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation.